Latest news
Loading news…
Versanis Bio
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Oakland, California, United States Founded 2021 11-50 employees For Profit
Versanis Bio discovers and develops medicines that address medical conditions prevalent in older adults.
Versanis Bio was acquired by Eli Lilly in 2023 for $2B.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
5
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 13
Company Info
- Founded
- 2021
- Employees
- 11-50
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 2
- News articles
- 41
- HQ
- Oakland, California, United States
- Region
- San Francisco Bay Area, West Coast, Western US
- Exit date
- Jul 14, 2023
Signals & Scores
- Heat score
- Low
- Growth score
- Low
- Trend (7d)
- 0.1
- Trend (30d)
- 3.7
- Trend (90d)
- -0.3
- Last leadership hire
- Jul 20, 2022
5
professional contacts at Versanis Bio
Contact execs at Versanis Bio →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Versanis Bio
Loading news…
FAQs about Versanis Bio
People who checked this page also checked these
Browse the full Acquirezy directory.